{"id":832769,"date":"2026-09-01T07:12:10","date_gmt":"2026-09-01T07:12:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/832769\/"},"modified":"2026-09-01T07:12:10","modified_gmt":"2026-09-01T07:12:10","slug":"trumps-pharma-pricing-deal-expands-as-healthcare-stocks-keep-climbing","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/832769\/","title":{"rendered":"Trump&#8217;s Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing"},"content":{"rendered":"<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/16596b4b72d510530e52c8d26f698cae237025e0a82a0100f6b17798b93fbc44\/lightyear_networkapi\/resizefit_w960%3Bquality_80%3Bformat_webp\/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbeincrypto_us_662%2F435e3f16b3c1f229fdd837352520b5dc.png\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Trump pharma pricing deal healthcare stocks rally. Photo by BeInCrypto\" height=\"540\" width=\"960\" class=\"yf-1f8hkhu loader\"\/><\/a> Trump pharma pricing deal healthcare stocks rally. Photo by BeInCrypto           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Healthcare stocks wrapped up their best quarter yet, and UBS says the rally still has room to run. President Trump added nine more pharmaceutical firms to his drug-pricing deal on Monday.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Michael Yee, UBS&#8217;s global head of biotechnology equity research, told CNBC the advance reflects a stack of major clinical wins. He said new pricing deals have also calmed fears of a broader industry crackdown.  <\/p>\n<p>            Nine New Agreements          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Trump announced the nine new agreements at the White House on Monday. He said the combined pricing deals struck over the past year would save Americans more than $600 billion.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The nine additional firms are mostly midsize drugmakers, including Alcon, Astellas Pharma, and Teva Pharmaceuticals. The companies pledged $19.6 billion combined toward U.S. manufacturing, according to a White House fact sheet.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">They also agreed to offer their drugs to every state Medicaid program at discounted prices.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The White House said 17 companies had already joined the pricing framework over the past year.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">&#8220;With today&#8217;s announcement, we now have 26 companies representing 90% of the domestic pharmaceutical market, and the other 10% are also coming in. They have no choice.&#8221;  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">President Trump, via CBS News  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The SPDR S&amp;P Biotech ETF, XBI, has climbed 80% in the last 12 months. That run has outpaced most other equity sectors.  <\/p>\n<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/07a28a42dd2a1b39a541fedf6341ab094a1caf92f8e5ef2a7c182fd05453c335\/lightyear_networkapi\/resizefit_w960%3Bquality_80%3Bformat_webp\/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbeincrypto_us_662%2F642781756e7add06e04df976ac4c77b9.png\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Biotech and medical stocks are rising.\" height=\"393\" width=\"960\" class=\"yf-1f8hkhu loader\"\/><\/a> Biotech and medical stocks are rising. Image Source: Trading View           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Yee said the pricing deals have proven less onerous than feared, and that they have removed a major source of uncertainty for the sector.  <\/p>\n<p>        Merck and Revolution Medicines Lead the Charge          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Yee named Merck as one of his top picks. The company&#8217;s melanoma vaccine, developed with Moderna, met its main trial goals in a large trial. The study included more than 1,100 patients and reported results on August 19.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><iframe loading=\"lazy\" title=\"UBS Michael Yee: We&amp;apos;ve been quite bullish on the pharma sector\" width=\"1200\" height=\"675\" src=\"https:\/\/www.youtube.com\/embed\/-FamVNf4DVo?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">He also flagged Merck&#8217;s antibody-drug conjugate sacituzumab tirumotecan. The drug posted a positive lung cancer trial readout earlier this year. It is now being tested across 17 late-stage studies.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Revolution Medicines was another name Yee highlighted. The Food and Drug Administration approved its pancreatic cancer drug daraxonrasib on August 26. The therapy nearly doubled median survival in a late-stage trial compared with chemotherapy.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Yee also named Bristol Myers Squibb. UBS carries a Buy rating on the stock and expects several late-stage trial readouts before year-end. Those catalysts could help offset revenue lost to patent expirations.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Yee said pharmaceutical companies are sitting on record cash piles. They are pushing more of it into research and development after a multiyear stretch of cheap valuations. Valuations are still not stretched, and Washington&#8217;s pricing overhang is easing. Yee said the current move looks more like the start of a longer re-rating than a short-lived bounce.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Read the Original story <a href=\"https:\/\/beincrypto.com\/trump-pharma-pricing-deal-healthcare-stocks\/\" data-ylk=\"slk:Trump&#039;s%20Pharma%20Pricing%20Deal%20Expands%20as%20Healthcare%20Stocks%20Keep%20Climbing;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Trump&#039;s Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Trump&#8217;s Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing<\/a> by Darryn Pollock at <a href=\"https:\/\/beincrypto.com\" data-ylk=\"slk:beincrypto.com;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;beincrypto.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">beincrypto.com<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"Trump pharma pricing deal healthcare stocks rally. Photo by BeInCrypto Healthcare stocks wrapped up their best quarter yet,&hellip;\n","protected":false},"author":2,"featured_media":832770,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[97,252,253,138363,193317,352627,352628,25008,3479,126985],"class_list":["post-832769","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-health","tag-health-care","tag-healthcare","tag-merck","tag-revolution-medicines","tag-the-food-and-drug-administration","tag-the-spdr-sp-biotech-etf","tag-the-white-house","tag-trump","tag-yee"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/832769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=832769"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/832769\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/832770"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=832769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=832769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=832769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}